Ali Guermazi, MD, PhD, MSc

Ali Guermazi, MD, PhD, MSc 


November 11, 2022 —  The 2022 Radiological Society of North America (RSNA) Alexander R. Margulis Award for Scientific Excellence will be presented to Ali Guermazi, M.D., Ph.D., M.Sc., for the Radiology article, “Improving Radiographic Fracture Recognition Performance and Efficiency Using Artificial Intelligence.” 

Named for Alexander R. Margulis, M.D., a distinguished investigator and inspiring visionary in the science of radiology, this annual award recognizes the best original scientific article published in RSNA’s flagship journal, Radiology. 

“This year’s Margulis Award recognizes the increasing importance of artificial intelligence in our field. The authors studied fracture detection by 24 radiologists and clinicians with and without AI,” said Radiology editor David A. Bluemke, M.D., Ph.D. “Ten percent better fracture detection was present using AI, while reducing time for radiologists. This study validates the steady rise in the use of AI tools that are becoming a routine part of many clinical practices, particularly in musculoskeletal radiology.” 

In the Food and Drug Administration (FDA) registration study, the researchers retrospectively analyzed 480 X-ray examinations from various U.S. hospitals. 

“AI can be a powerful tool to help radiologists and other physicians improve diagnostic performance and increase efficiency, while potentially improving patient experience at the time of hospital or clinic visit,” said Dr. Guermazi, director of the Quantitative Imaging Center, professor of radiology and medicine, and assistant dean in the office of diversity at Boston University Chobanian & Avedisian School of Medicine and chief of radiology at VA Boston Healthcare System. 

The researchers included X-rays of limbs, pelvis, spine and rib cage. The exam group included adults over 21 years of age with indications of trauma and fracture prevalence of 50%. There were 240 patients with a total of 350 fractures, and 240 patients with no fractures. 

The studies were analyzed twice by 24 U.S. board-certified readers from six different specialties including radiology, orthopedic surgery, rheumatology, emergency medicine (including physicians and physician assistants) and family medicine. 

According to Dr. Guermazi, readings were performed both with and without a commercially developed software utilizing an algorithm trained on accurately annotated X-ray images from multiple institutions, acquired on a large variety of systems. Readers had a one-month period between the two analyses. 

“The results of the study showed an absolute gain in sensitivity in the detection of fractures of 10.4% with the help of the software, with the software showing a sensitivity of 75.2% against 64.8% without the assistance of the software,” Dr. Guermazi said. The results also revealed an absolute gain in specificity—from 90.6% to 95.6%—for fracture detection with software assistance. 

While not surprised by the algorithm’s sensitivity, Dr. Guermazi did not expect the gain in specificity. 

“Computer-aided detection systems can be easily sensitive but usually bring significant loss in specificity. Here, the algorithm also helped reduce false-positive rates,” he said. “The time saving was a good surprise, given that the algorithm brings additional information to look at on top of the native images. It was not obvious that the algorithm would speed up interpretation time.” 

Dr. Guermazi noted that one of the most important challenges the team faced during the study was training 24 readers with various backgrounds on reading with AI. Despite this challenge, he said the readers thought the use of the AI algorithm was easy, friendly and extremely intuitive. 

Clinical validation studies are ongoing with a focus on specific body parts where, according to Dr. Guermazi, the gold standard is established using CT/MRI to evaluate the algorithm’s ability to detect radiographically visible and occult lesions. 

“Ultimately, I believe my radiology colleagues will join in viewing AI as a friend rather than a foe,” Dr. Guermazi said. “As it becomes clearer that it can beat the human eye at certain specific and repetitive or tedious tasks, AI will be viewed as a great add-on to heavy clinical workflow.” 

The Margulis Award will be presented during the RSNA 108th Scientific Assembly and Annual Meeting (RSNA 2022) in Chicago, Nov. 27-Dec. 1. 

For more information: www.rsna.org 


Find more RSNA22 coverage here  


Related Content

Feature | X-Ray | By Siân Phillips, MD

Imaging is a crucial diagnostic, treatment and monitoring tool in modern medicine. From diagnosis to disease management ...

Time July 31, 2025
arrow
News | Digital Radiography (DR)

July 30, 2025 — Fujifilm Healthcare Americas Corp., a leading provider of diagnostic and enterprise imaging solutions ...

Time July 30, 2025
arrow
News | Advanced Visualization

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Time July 28, 2025
arrow
News | X-Ray

July 24, 2025 — GE HealthCare has announced the commercial availability of an advanced floor-mounted digital X-ray ...

Time July 24, 2025
arrow
News | Artificial Intelligence

July 17, 2025 — HOPPR, a secure AI development platform for medical imaging, has announced the commercial release of its ...

Time July 17, 2025
arrow
News | Breast Imaging

July 17, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time July 17, 2025
arrow
News | Focused Ultrasound Therapy

July 15, 2025 — Newswise —The UK Focused Ultrasound Foundation and Pancreatic Cancer UK have announced a new partnership ...

Time July 16, 2025
arrow
News | Radiology Imaging

July 15, 2025 — Radiology Partners (RP), a provider of technology-enabled radiology services, has announced the launch ...

Time July 15, 2025
arrow
News | Digital Radiography (DR)

July 10, 2025 — Fujifilm Healthcare Americas Corp. has launched several advanced automated functions for its FDR ...

Time July 10, 2025
arrow
News | Prostate Cancer

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time July 09, 2025
arrow
Subscribe Now